Oncolytic Reovirus in Combination with Paclitaxel/Carboplatin in NSCLC Patients with Ras Activated Malignancies, Long Term Results

被引：0
|
作者：
Villalona, Miguel [1 ]
Lam, Elaine [1 ]
Otterson, Gregory [1 ]
Zhao, Weqiang [2 ]
Timmons, Matthew [3 ]
Subramaniam, Deepa [4 ]
Hade, Erin [5 ]
Bertino, Erin [5 ]
Chao, Bo [1 ]
Selvaggi, Giovanni [6 ]
Knopp, Michael [7 ]
Gill, George M. [6 ]
机构：
[1] Ohio State Univ, Internal Med, Columbus, OH 43210 USA
[2] Ohio State Univ, Pathol, Columbus, OH 43210 USA
[3] Ohio State Univ, Canc Ctr, Columbus, OH 43210 USA
[4] Georgetown Univ, Med Oncol, Washington, DC USA
[5] Ohio State Univ, Dept Med Informat, Ctr Biostat, Columbus, OH 43210 USA
[6] Oncolytics Inc, Clin Dev, Calgary, AB, Canada
[7] Ohio State Univ, Radiol, Columbus, OH 43210 USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
reovirus; Kras activation; BRAF; long term survival;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI30.01
引用
收藏
页码：S372 / S372
页数：1
相关论文
共 50 条
  • [31] Radiotherapy and concurrent daily carboplatin/paclitaxel in stage III non-small cell lung cancer (NSCLC). Long-term results of a phase II trial
    Jeremic, B
    Milicic, B
    Acimovic, L
    Milisavljevic, S
    Radosavljevic-Asic, G
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 : 33 - 33
  • [32] Volociximab (V) in combination with carboplatin (C) and paclitaxel (P) in patients (pts) with advanced non small cell lung cancer (NSCLC)
    Belani, Chandra P.
    Tsao, Claire
    Almokadem, Salah
    Ding, Han
    Chico, Isagani M.
    Soria, Jean-Charles
    Besse, Benjamin
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S444 - S445
  • [33] Meloxicam (M) in combination with paclitaxel (P) and carboplatin (C) in patients with advanced non-small cell lung cancer (NSCLC).
    Takahashi, T
    Kogure, Y
    Ueda, S
    Ebisawa, M
    Asai, G
    Yamamoto, N
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 649S - 649S
  • [34] Volociximab (V) in combination with carboplatin (C) and paclitaxel (P) in patients (pts) with advanced non small cell lung cancer (NSCLC)
    Besse, B.
    Soria, J. C.
    Chico, I.
    Tsao, C.
    Ding, H.
    Belani, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 547 - 547
  • [35] Sunitinib combined with pemetrexed and carboplatin in patients with NSCLC and other advanced solid malignancies: maximum tolerated dose and safety results
    Chow, Laura Q. M.
    Blais, Normand
    Jonker, Derek J.
    Soulieres, Denis
    Laurie, Scott A.
    Diab, Sami G.
    Ruiz-Garcia, Ana
    Thall, Aron
    Chao, Richard
    Eckhardt, S. Gail
    Camidge, D. Ross
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S672 - S672
  • [36] Nab-paclitaxel in combination with carboplatin as first line therapy for patients with stage IIIB/IV NSCLC in the real-world setting: Interim results of the NEPTUN study
    Dechow, T.
    Riera-Knorrenschild, J.
    Schulz, H.
    Janssen, J.
    Chiabudini, M.
    Koszinowski, S.
    Potthoff, K.
    Runkel, E.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 296 - 296
  • [37] Results of a phase 2 study of STA-4783 in combination with paclitaxel and carboplatin in patients with previously untreated advanced non-small cell lung cancer (NSCLC)
    Hainsworth, J
    Weber, R
    Jacobs, M
    Fehrenbacher, L
    Schwartzberg, L
    Kalman, L
    Mills, G
    Dooley, W
    McLeod, M
    Dahl, TA
    Sherman, MS
    Salgia, R
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 9059S - 9059S
  • [38] Treatment of primary advanced and recurrent endometrial carcinoma with a combination of carboplatin and paclitaxel - long-term follow-up
    Sorbe, B.
    Andersson, H.
    Boman, K.
    Rosenberg, P.
    Kalling, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2008, 18 (04) : 803 - 808
  • [39] Oncolytic reovirus in combination with chemotherapy in metastatic or recurrent non-small cell lung cancer patients with KRAS-activated tumors
    Villalona-Calero, Miguel A.
    Lam, Elaine
    Otterson, Gregory A.
    Zhao, Weiqiang
    Timmons, Matthew
    Subramaniam, Deepa
    Hade, Erinn M.
    Gill, George M.
    Coffey, Matthew
    Selvaggi, Giovanni
    Bertino, Erin
    Chao, Bo
    Knopp, Michael V.
    CANCER, 2016, 122 (06) : 875 - 883
  • [40] Clinical outcomes of bevacizumab in combination with paclitaxel/carboplatin compared with paclitaxel/carboplatin alone in previously untreated Japanese patients with advanced non-squamous non-small-cell lung cancer (NSCLC)
    Ichinose, Y.
    Seto, T.
    Kunitoh, H.
    Horai, T.
    Nishiwaki, Y.
    Hida, T.
    Yamamoto, N.
    Kawahara, M.
    Saijo, N.
    Fukuoka, M.
    EJC SUPPLEMENTS, 2009, 7 (02): : 508 - 508
12345